ExodusPoint Capital Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,037
Closed -$338K 2103
2024
Q1
$338K Sell
1,037
-28,022
-96% -$6.88M ﹤0.01% 1228
2023
Q4
$5.54M Sell
29,059
-36,555
-56% -$6.91M 0.04% 321
2023
Q3
$13.1M Buy
65,614
+42,534
+184% +$10.1M 0.12% 175
2023
Q2
$6.59M Buy
+23,080
New +$6.41M 0.05% 355
2023
Q1
Sell
-12,860
Closed -$2.64M 2209
2022
Q4
$2.64M Buy
12,860
+5,532
+75% +$1.4M 0.04% 536
2022
Q3
$2.04M Buy
+7,328
New +$1.86M 0.03% 793
2022
Q2
Sell
-3,529
Closed -$732K 2589
2022
Q1
$732K Buy
+3,529
New +$582K 0.01% 1331
2021
Q4
Sell
-6,354
Closed -$1.31M 2712
2021
Q3
$1.31M Buy
+6,354
New +$1.25M 0.02% 906
2021
Q1
Sell
-4,819
Closed -$500K 2709
2020
Q4
$500K Buy
4,819
+4,807
+40,058% +$416K ﹤0.01% 1252
2020
Q3
$1K Sell
12
-35,129
-100% -$1.99M ﹤0.01% 1679
2020
Q2
$1.67M Buy
+35,141
New +$1.45M 0.04% 500
2019
Q2
Sell
-8,335
Closed -$279K 1384
2019
Q1
$279K Buy
+8,335
New +$277K 0.02% 490

Other funds holding SWAV

ExodusPoint Capital Management's SWAV Position: Q2 2024 in Review

ExodusPoint Capital Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 1,037 shares — an estimated $338K sold.

ExodusPoint Capital Management first reported a position in SWAV in Q1 2019 and held it in 12 quarters. The position peaked at $13.1M in Q3 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • ExodusPoint Capital Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • ExodusPoint Capital Management sold 1,037 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $338K.
  • ExodusPoint Capital Management first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 12 quarters.
  • ExodusPoint Capital Management's Shockwave Medical, Inc. Common Stock position peaked at $13.1M in Q3 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on ExodusPoint Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.